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Abstract
Acinetobacter baumannii is an opportunistic bacterium that causes hospital- acquired infections with a high mortality and mor-
bidity, since there are strains resistant to virtually any kind of antibiotic. The chase to find novel strategies to fight against this 
microbe can be favoured by knowledge of the complete catalogue of genes of the species, and their relationship with the spe-
cific characteristics of different isolates. In this work, we performed a genomics analysis of almost 2500 strains. Two different 
groups of genomes were found based on the number of shared genes. One of these groups rarely has plasmids, and bears 
clustered regularly interspaced short palindromic repeat (CRISPR) sequences, in addition to CRISPR- associated genes (cas 
genes) or restriction- modification system genes. This fact strongly supports the lack of plasmids. Furthermore, the scarce plas-
mids in this group also bear CRISPR sequences, and specifically contain genes involved in prokaryotic toxin–antitoxin systems 
that could either act as the still little known CRISPR type IV system or be the precursors of other novel CRISPR/Cas systems. 
In addition, a limited set of strains present a new cas9- like gene, which may complement the other cas genes in inhibiting the 
entrance of new plasmids into the bacteria. Finally, this group has exclusive genes involved in biofilm formation, which would 
connect CRISPR systems to the biogenesis of these bacterial resistance structures.
DATA SummARy
All supporting data, code and protocols used during this 
study have been provided in the supplementary material 
(available with the online version of this article) and in the 
GitHub repository (https:// github. com/ upobioinfo/ aba).
InTRoDuCTIon
Multidrug- resistant Acinetobacter baumannii causes hospital- 
acquired endemic and outbreak infections with high mortality 
and morbidity rates. Recently, the World Health Organiza-
tion has classified carbapenem- resistant A. baumannii as 
priority one for the development of new antibiotics in the 
fight against the species [1]. This pathogen can colonize the 
human body or even persist in the hospital environment 
[2, 3], and opportunistically causes pneumonia, urinary 
tract infections and occasionally bacteraemia [4]. It has also 
been isolated from other animals [5], although some authors 
propose that these isolates are really other species of the same 
genus [6]. A. baumannii has a wide collection of genes, and 
many of them are known to contribute to its virulence, such 
as several outer- membrane proteins and siderophores [7, 8]. 
Some genes can be transferred by plasmids, which allows 
the bacteria to adapt to the environment [9]. The knowledge 
of the whole set of genes of a particular strain, in addition 
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to the virulence information, could be important to predict 
the strain's expected pathogenicity. This is now possible due 
to the vast availability of genomics data stored in molecular 
databases [10].
Currently, thousands of sequences of complete genomes of 
A. baumannii are available from different genomics projects. 
Therefore, we can compare such genomes and associate genes 
with characteristics of the strains, e.g. the isolation source 
or the disease that they caused. The set of shared genes in 
this species has been calculated in numerous projects with 
a limited number of strains, and it amounts to around 2000 
genes [2, 11–14]. But it is estimated that the number of genes 
in the core genome (genes shared by all the strains) is around 
2200, with 20 000 in the pangenome (genes coming from all 
the strains) [15, 16]. However, a study with thousands of 
genomes has never been carried out; the previous ones were 
usually performed with a restricted number of A. baumannii 
isolates, and might not reflect the complete scenario.
We studied a set of genes from almost 2500 genomes of A. 
baumannii, and discovered that a few of them could be erro-
neously classified in this species and others have a very low 
quality that does not justify their use in genomics studies. 
From the remaining genomes, we validated the previous esti-
mations for core genome and pangenome, and found that a 
small group of strains share a lower number of genes due to 
the lack or low prevalence of plasmids. Remarkably, many 
strains in this group have a high number of clustered regularly 
interspaced short palindromic repeats (CRISPRs), although 
only half of strains have the genes of CRISPR/Cas systems, 
which are an essential prerequisite for the proper functioning 
of these systems. In A. baumannii, only the CRISPR type I–F 
system has been found so far, which is characterized by a 
cluster with the genes cas1, cas2_3, cas8f, cas5, cas7 and cas6f 
[17]. However, we found one strain with a putative CRISPR 
type IV system, which has been mainly described in plasmids 
[18]. The group of strains with a lower number of plasmids 
also contains a high number of genes from toxin–antitoxin 
systems, which have been proposed to be precursors of 
modules of the CRISPR type IV system, but are still not very 
well known [18, 19]. Finally, another set of strains in this 
group has a homologue of the cas9 gene, one of the most 
currently used genes in genetic engineering [20], with only 
the endonuclease domain conserved. All of this suggests there 
are new CRISPR elements in A. baumannii, with the potential 
for use in the future in the study of virulence relationships 
[21].
mETHoDS
Genome collection
Assembled sequences of A. baumannii stored in the National 
Center for Biotechnology Information (NCBI) genome 
database as of January 2018 were collected, including 2467 
genomes (98 completed and 2369 draft genomes). Metadata 
were also collected for each genome both from GenBank 
database and BioSample entries, which included, among 
others (Table S1), information on the assembly about the 
collection date, country, isolation source, host disease or host 
disease outcome [22]. The sequences of genomes of the other 
species from the genus Acinetobacter were also collected from 
the same source, including 490 additional genomes coming 
from 51 different species. Three of them were considered as 
part of the Acinetobacter ACB complex (Acinetobacter pittii, 
Acinetobacter nosocomialis and Acinetobacter calcoaceticus), 
where A. baumannii is usually grouped [23]. The remaining 
species were tagged as ‘other’.
The metadata were filtered and only those with a high repre-
sentativeness were used. We joined isolates from homoge-
neous sources to have the most numerous groups: blood 
(blood cultures), catheters, inert surfaces, non- human hosts 
(cat, chicken, dog, goose, parrot, stork and a plant), bone/
joints (bone and joints samples), perianal (mainly perianal 
swabs), respiratory airways, skin and soft tissues, urinary 
tract, and others (the remaining infrequent sources). To create 
these general groups, we used both isolation source and host 
disease categories.
Genome and gene annotation
To homogenize the genome annotation, the sequences of all 
genomes were analysed using the same protocol. The protein- 
encoding genes were predicted using Prokka version 1.13 
[24], and the predicted protein sequences were functionally 
annotated using Sma3s v2 and UniProt taxonomic division 
bacteria 2019_01 as a reference database [25, 55].
To annotate specific genes, GO (gene ontology) terms and 
UniProt keywords assigned by Sma3s were used. To find genes 
associated with CRISPR systems, protein sequences coming 
Impact Statement
Thousands of complete bacterial genomes are currently 
available in public databases. We have performed an in 
silico strategy for analysing the pangenome of almost 
2500 strains of Acinetobacter baumannii and found that 
the genomes are divided into two groups with regard to 
the mean number of shared genes. The group sharing a 
lower number of genes rarely has plasmids, half of the 
strains from this group have genes from clustered regu-
larly interspaced short palindromic repeat (CRISPR)/
Cas systems, and the majority of strains always have 
CRISPR arrays. In addition, this group has specific genes 
from toxin–antitoxin systems, which have already been 
proposed as ancestral elements of CRISPR/Cas systems. 
All of this constitutes a demonstration that CRISPR/
Cas systems prevent the acquisition of new genes in A. 
baumannii. Finally, this group of strains, despite the pres-
ence of a low number of shared genes, has specific genes 
involved in biofilms that would link CRISPR/Cas systems 
with this bacterial resistance structure, and could consti-
tute new elements involved in both prokaryotic immunity 
and virulence.
3Mangas et al., Microbial Genomics 2019;5
from UniProt bacteria 2019_05 that had the word CRISPR 
(mainly with the GO term GO:0043571; maintenance of 
CRISPR repeat elements) were collected. Then, homologues 
to these proteins were searched for in all the A. baumannii 
strains, with a minimal identity threshold of 30 and 80 % of 
query coverage. To complete the dataset of cas genes, CRISPR/
Cas domains from the Conserved Domain Database (CDD) 
were searched for in the proteins of the pangenome. A total of 
134 PSSM (position- specific scoring matrix) from the CDD 
[26] were searched using rps- blast from the blast 2.2.31+ 
package [27], and 1×10−5 as the E value threshold. Finally, 
when a cluster of cas genes was found in a strain, and 1–3 
unknown genes were inside the cluster, these new genes were 
also included.
Phylogenetic analysis
To create the 16S rRNA phylogenetic tree, the 16S rRNA gene 
sequences were searched by the software ssu- align v0.1.1 and 
Infernal v1.1 with default parameters [28]. Only genomes 
that showed a complete 16S rRNA gene (with the expected 
length of this gene in Acinetobacter) were taken into account, 
and when several 16S rRNA genes were found, the longest 
one was used. Then, the most probable 16S rRNA gene for 
each strain was used to do a multiple alignment using mafft 
v7.271 [29], the auto mode and default options, because of the 
high expected sequence similarity. Gap regions appearing in 
more than 10 % of the sequences were removed using trimAL 
v1.2 [30]. The phylogeny was finally created with the align-
ment and the tool dnapars from the suite phylip v3.697, 
which uses the parsimony method. A bootstrap of 1000 was 
calculated to evaluate the phylogeny confidence.
The core phylogeny was created with the amino acid sequences 
of genes present in the strains of all Acinetobacter genera 
(184 strains of non-A. baumannii genomes were removed 
due to low quality). The core proteins of A. baumannii were 
searched in the remaining species by the standalone version 
2.2.31+ of blast [27], using the reference core sequences of A. 
baumannii as query sequences, and 70 % both for identity and 
query coverage as thresholds. This resulted in 14 sequences, 
mainly annotated in metabolism, translation or ribosome 
biosynthesis: rplB, spot, rpmC, cgtA, hemF, aroK, proB, lolD, 
gmk, lysA, purM, recG, truB and rpoA. The sequences were 
joined and aligned by mafft v7.271 using the L- INS- I option. 
Gap regions appearing in more than 10 % of the sequences 
were also removed using trimAL v1.2. The phylogeny was 
reconstructed by RAxML v8.2.9 with the model PROTGAM-
MAWAG and bootstrap of 1000 [31]. Both trees were viewed 
by R ggtree v1.10.5.
To calculate the average nucleotide identity (ANI), pyani 
v0.2.4 with method ANIb and blastn was used [32]. All 
strains were compared against the reference strain ATCC 
17978, and the ANI percentages were collected.
Core genome and pangenome assessment
To assess the core genome and pangenome, Roary version 
3.11.2 was used with an identity threshold of 90 % and the 
-s parameter for not separating paralogs at this identity 
threshold [33]. This process creates groups of genes that 
assume the same gene coming from different strains, and 
each group is represented by a reference sequence. Only 
protein- encoding genes were considered. To be more 
exhaustive and to try to discover all the corresponding 
genes in all the strains, the reference genes were function-
ally annotated by Sma3s, and proteins with the same gene 
name were collapsed. In this way, we have a high confidence 
in the presence/absence of every gene in the pangenome. 
Finally, when a group contains genes from all the selected 
strains it is considered to be a core gene (we considered that 
a gene belonged to the core genome when it appeared in 
99 % of the strains), and the remaining genes are considered 
as accessory genes. The annotations of genes with the same 
gene name were combined to improve the functional infor-
mation for these genes, since many of them are fragments 
coming from the same gene that has repeats that are hard 
to assemble.
The list of presence/absence of genes was used to recon-
struct a phylogenetic profile that groups the strains by the 
co- occurrence of shared genes. The tree was created by Roary 
and FastTree 2.1.8 [34], and the results were viewed by the 
Phandango web application [35] and exported in SVG format.
Functional enrichment analysis
To discover the functional enrichment of a group of genes, 
such as the core genome or the different groups from the 
accessory genome, TopGO R package version 2.30.1 was 
used [36], which uses GO terms from a specific ontology 
(biological process was selected). The GO terms used were 
those annotated by Sma3s. The figures were created using 
the ggplot2 R library in a customized script.
UniProt keywords were included as an additional anno-
tation source to enrich the two groups of strains sharing 
a different number of genes. In this case, the enrichment 
protocol of the module 3 from Sma3s was used [37], which 
is based on the hypergeometric distribution. We analysed 
all functional annotations from genes present in at least 
in 30 % of the strains of a group and in less than 5 % of 
the other group. Annotation terms with a P value higher 
than 0.01 were selected and terms appearing in only one 
gene were not considered. The two groups were chosen by 
the minimum point in the distribution of the mean shared 
genes.
CRISPR array discovery
To collect the plasmids bearing CRISPR arrays, the term 
‘CRISPR Arrays’ was searched for in the COMMENT field 
of their GenBank entry, and the plasmid was annotated as 
containing CRISPR- repeats when it appeared. To discover 
CRISPR repeats in the complete genomes, CRISPRCas-
Finder 1.4 was used with default parameters [38]. The 
number of CRISPR arrays with an evidence- level ≥1 in each 
genome was counted and assigned to the genome.
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Fig. 1. 16S rRNA- based phylogenetic tree. The three rings around the tree represent: the species (2139 from A. baumannii, 166 from the 
ACB complex, 3 similar related Acinetobacter species that are usually grouped in this complex together with A. baumannii and 140 from 
other species of the genus); the percentage similarity with the reference A. baumannii ATCC 17978 measured as the ANI; and the number 
of strains in the terminal node (strains with exactly the same 16S rRNA sequence were collapsed in one node). A bootstrap of 1000 
repeats was used, and nodes with a bootstrap lower than 70 % are marked with a red circle . A total of 328 strains from A. baumannii 
and 184 from the other species were not used in this phylogeny due to the absence of a complete 16S rRNA gene. Only strains of the A. 
baumannii clade in the upper- left corner were retained in the study.
Plasmid discovery
When a genome sequence is closed, the plasmids coming from 
this genome are known and can be used; but when the genome 
sequence is a draft, it is necessary to predict the plasmids. To 
do that, plasmids in the NCBI RefSeq nucleotide database were 
searched by the term: 'Acinetobacter baumannii[Organism]', 
taking only records from the genetic compartment 'Plasmid' 
that had at least one of the two terms ‘complete sequence’ 
or ‘complete genome’ in their Description field. Thus, 
partial sequences and those lower than 1 kb in length were 
discarded. In this way, 638 plasmids were downloaded. Then, 
homologues to these plasmids in the A. baumannii strains 
were searched by blastn with both an identity and plasmid 
coverage threshold of 95 %. Only sequences from the strains 
with a minimal coverage of 95 % were considered to be more 
restricted. The candidate plasmids in the different strains were 
later clustered by psi- CD- HIT, an implementation of CD- HIT 
for long sequences [39], with an identity threshold of 90 % 
to remove redundant plasmids, and the remaining sequences 
were clustered by mob_cluster from the Mob- Suite toolkit 
v1.4.9.1 [40], which uses default parameter to cluster plasmid 
sequences. Finally, all the clustered plasmids were considered 
the same plasmid in the different strains. The final number of 
non- redundant plasmids was 84, although only 48 of them 
were found in the analysed genomes.
RESuLTS
Genome collection and phylogenetic analysis
The first step in the analysis of the set of genes present in A. 
baumannii was collecting 2467 available genome sequences 
from public databases, together with descriptive information, 
including their isolation source. To estimate the quality of the 
genomes and measure the evolutionary relationship among 
them, a 16S rRNA- based phylogeny was reconstructed. This 
included the 16S rRNA gene sequences from all the strains, 
although for 328 of them no complete 16S rRNA gene was 
found and, thus, we discarded these strains from later anal-
ysis. The phylogeny also included the 16S rRNA sequences 
of 490 strains from other species of the genus Acinetobacter, 
which allowed us to assess the validity of the A. baumannii 
taxonomic assignments (Fig. 1). The result showed that 14 
strains could belong to species other than A. baumannii 
from the same genus. As a consequence, only 2125 strains 
were finally kept for further analysis (Table 1). The highest 
number of discarded genomes belonged to the group of blood 
and perianal isolation sources. It suggests that some strains 
causing bloodstream infections or collected from surveillance 
studies in the perianal region either are wrongly classified as 
A. baumannii or have incomplete genomes. It is also remark-
able that none of the non- human host strains, coming from 
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Table 1. Number of genomes from the different isolation sources
Frequencies are shown before and after the 16S rRNA analysis. The 
last column shows the frequencies after the posterior low- quality test, 
where 13 additional strains were discarded. Some sources have been 
homogenized, and the ‘others’ class includes both low frequency and 
non- reported sources.
Number of strains
Isolation source classes Initially After 16S 
rRNA
Finally
Respiratory airways 814 777 773
Blood 285 166 163
Skin and soft tissues 155 139 139
Urinary tract 130 126 126
Perianal 151 83 83
Inert surfaces 35 21 21
Non- human hosts 17 17 17
Catheters 15 15 14
Bone/joints 16 9 9
Others 849 772 767
Total strains 2467 2125 2112
animals (mainly birds) and plants (Table S1, available with 
the online version of this article), were discarded after phylo-
genetic analysis.
Average number of shared genes among strains
Protein- encoding genes were predicted, and orthologous 
genes were clustered using a restricted strategy. Two genes 
from different strains were considered orthologues when they 
had the same predicted gene name or shared ≥90 %amino 
acid identity. The core genome and pangenome were found 
to be 2221 and 19 272 genes, respectively (Table S2). Func-
tional annotation of the pangenome showed that 42 % of 
the genes were not assigned any function. However, only 
3 % of such genes were in the core genome (Table S3). The 
different genomes show a similar number of genes, with a 
mean around 3600 (Fig. 2a). However, the average number of 
shared genes by strain shows a bimodal distribution with two 
mean values, where the second group of strains shares about 
150 more genes (Fig. 2b). Both distributions show outliers 
with extremely low values, which would represent genomes 
of low quality, and they were discarded from later analysis. In 
fact, when correlating the two distributions, extreme values 
suggest both low- quality genomes and misclassification of 
the species name, sometimes matching to strains previously 
discarded after the 16S rRNA- based phylogeny (Fig.  2c). 
So, strains removed because they previously brought other 
Acinetobacter species into the phylogeny showed a number 
of shared genes under that expected based on their total 
number of genes, and many of the strains not showing the 
16S rRNA gene have a low total number of genes, suggesting 
a low quality of the genome assembly. It is notable that three 
strains isolated from blood cultures were discarded at this 
stage (Table 1).
When analysing the total number of genes and the number 
of shared genes, another meaningful fact is that the non- 
human host strain correlated with the majority of other A. 
baumannii strains, highlighting again the isolation of this 
species in animals. Alternatively, strains isolated from inert 
surfaces, mainly hospital equipment and furniture, showed 
a low number of shared genes, or did not show 16S rRNA 
genes, and some of them were removed from the final 
dataset.
Functional enrichment of the core genome and 
pangenome
Once the most contradictory genomes were discarded, the 
total number of A. baumannii strains was 2112. These strains 
have more than 19 000 different genes, though the majority, 
almost 16 000 genes, are present only in less than 20 % of the 
strains. The core genome is highly enriched in genes involved 
in metabolism, biosynthesis and protein translation functions 
(Fig. 3). Specifically, more than 450 genes are involved in 
organonitrogen compound metabolic processes, and almost 
400 in small molecule metabolic processeses. However, the 
accessory genome (genes present in only some strains) is 
enriched mainly in regulation functions, with more than 90 
genes involved in transcription processes. Expression regu-
lation is mainly highlighted in genes present in more than 
20 % of strains and supports the previous idea that differences 
between A. baumannii isolates are strongly supported by a 
heterogeneous gene expression of the core genes [15, 41]. A 
remarkable function that appears in the limited accessory 
genome is ‘maintenance of DNA repeat elements’, which is 
mainly related to CRISPR/Cas systems. Finally, genes only 
appearing in 1 % of strains (21 or less) are related to both 
DNA modification and integration, characteristics of mobile 
sequences as transposons or sequences with phage origin. 
Although, it is noteworthy that the latter group also highlights 
the function cell motility, which would suggest motile strains 
in an essentially non- motile genus [2].
The core genome is an important reference in the analysis 
of phylogenetic relationships between strains. Thus, a new 
phylogeny was reconstructed with 14 genes present in the 
entire genus Acinetobacter. The tree obtained supports 
the relationships already found with the 16S rRNA- based 
phylogeny (Fig. S2). The tree brings together neither strains 
coming from the same source nor the two groups of strains 
sharing a different mean number of shared genes, although 
a small number of the strains sharing a low number of genes 
appear near to the node of other Acinetobacter ssp. However, 
the analysis of gene presence/absence from the pangenome 
suggests that both groups have specific genes, which rarely 
appear in the contrary group (Fig.  4). So, from now on, 
we name ‘group 1’ as the group sharing a lower number of 
genes, and ‘group 2’ as the group sharing a higher number 
of them.
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Fig. 2. Distribution of the number of genes and mean number of shared genes between strains. (a) Distribution of the number of genes 
for all the A. baumannii strains: total (total number of genes) and shared (genes shared with at least another different strain). The red 
dashed line marks the threshold below which strains were removed due to low quality (at 2.5 sd). (b) Distribution of the average number 
of shared genes for each strain against the other strains. The red dashed line marks the threshold below which strains were removed 
due to low quality (at 2.5 sd of the first peak), and the blue line marks the minimum in the distribution that highlights the separation 
between the two clearly independent groups of strains. The Hartigans' dip test for multimodality suggests non- unimodality with P 
value=2.2×10−16. (c) Scatter plot comparing the two previous distributions. Every point represents a strain, the colour shows the isolation 
source of this strain. The shape shows whether the strain was discarded due to low quality (triangle), the 16S rRNA gene was not found 
(x), the 16S rRNA phylogeny suggested that it was not A. baumannii (+) or the strain was retained as A. baumannii in the analysis (circle). 
An updated figure that only shows the strains remaining in the analysis can be reviewed in Fig. S1.
Strains with CRISPR systems usually lack plasmids
Groups 1 and 2 have 717 and 1395 strains, respectively. In 
addition, there are genes specifically found in each group, 
which seem to appear uniquely in the respective group 
(Fig.  4). Remarkably, genes in group 2 were enriched in 
plasmid annotation and also in exonuclease activity (Fig. 5), 
which could help plasmid maintenance [42]. Altogether, this 
result suggests that the higher number of shared genes in these 
strains could be due to the presence of plasmids bearing genes, 
which are not present in the other group. In fact, group 1 was 
mainly enriched in genes involved in maintenance of CRISPR 
repeat elements, which could, hence, be involved in avoiding 
plasmid entry into the bacteria. In addition, many genes in 
group 1 have signal peptides and encode membrane lipopro-
teins. Remarkably, four of these genes encode proteins bearing 
the spore coat protein U domain (P23_0613, XAC1424) or 
fimbrial biogenesis outer membrane usher proteins (yehB/
FimD, J532_1634/FimC). All of these genes could be involved 
in biofilm formation; therefore, they might be relevant in both 
surviving and virulence [43, 44]. They appear in more than 
70 % of strains of group 1 and less than 2 % of group 2, what 
suggests its relevance in the first group.
To confirm the inverse relationship between plasmids and 
CRISPR genes, both plasmids and CRISPR- associated genes 
(cas), in addition to CRISPR arrays, were searched for in the 
genomes of the different groups. As expected, the number of 
plasmids in group 1 was lower than in group 2, and group 
1 presented a much higher number of both cas genes and 
CRISPR arrays (Table 2, Fig. S3).
Only a small number of strains in group 1 have a high number 
of plasmids. But in these strains, plasmids bear CRISPR 
arrays, different to the case of group 2 (Fig.  6a). CRISPR 
arrays are usually in the bacteria chromosome, though they 
can also appear in plasmids [18]. In fact, 12 strains in group 
1 have plasmids with annotated CRISPR repeats. To measure 
the abundance of CRISPR systems in group 1 with regard 
to group 2, CRISPR arrays were predicted in the complete 
A. baumannii genomes. Nearly all group 1 strains are char-
acterized by a high number of CRISPR arrays, and half of 
them bear cas genes. However, only three- quarters of strains 
belonging to group 2 have CRISPR arrays. They appear in a 
much lower number, and do not match with cas genes in the 
same strains (Table 2, Fig. 6b). All of this suggests that to avoid 
plasmid entry, the bacterium needs to have not only cas genes 
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Fig. 3. Functional enrichment of the different pangenome groups. (a) Core genome (>99 % of strains; 2221 genes). (b) Accessory genome 
of frequent genes (20–99 % of strains; 1341 genes). (c) Accessory genome of limited genes (1–20 % of strains; 3074 genes). (d) Accessory 
genome of rare genes including singletons (<1 % of strains; 12 635 genes). Biological process ontology from GO was used. The x- axes 
show the number of genes with a GO term, and the colour shows the P value of the GO term. Note that the most significant terms appear 
in the core genome (coloured in red).
Fig. 4. Phylogenetic profile with a presence/absence matrix of all genes in the pangenome. The presence of a gene is indicated by the 
colour blue, and at the bottom of the figure the percentage of strains that have each gene is shown. The columns show: in mauve, the 
strains removed in previous steps; in orange, the strains belonging to group 1; and in purple, the strains belong to group 2. Note that the 
members of the groups 1 and 2 share specific genes with their group that do not appear in the other group, which are highlighted with 
dashed boxes. The arrow marks a strain with many specific genes (mostly fragments) that is in the group of discarded strains.
but also CRISPR arrays. In addition, strains in group 1 with 
CRISPR arrays but without cas genes might suggest either 
they previously had cas genes or that they have unknown 
CRISPR systems or even that they could bear another bacte-
rial immunity system. To test this hypothesis, genes in the 
strains of group 1 that had no cas genes were analysed. From 
this study, 11 genes emerged, which were present in 82 % of 
the strains of group 1 and only in 3 % of group 2 strains. More 
specifically, the genes were hsdS, mshD, yjhX, pepO, moeA_2, 
kstR and five unknown genes (annotated as BIT33_04875, 
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Fig. 5. Functional enrichment of the strains from groups 1 and 2. GO terms (lowercase), and UniProt keywords and descriptions 
(uppercase) were used as the annotation sources. The x- axis shows the number of genes with a term, and the colour shows the P 
value of the term. Note that the most significant terms are signal and maintenance of CRISPR repeat element in group 1, and plasmid and 
exonuclease activity in group 2.
Table 2. Number of plasmids and CRISPR genes in both group 1 and 
group 2
The number of plasmids, cas genes and CRISPR arrays is shown, and 
also the proportion of strains with at least one of them in the group 
(in brackets). The remaining strains bearing cas genes have different 
variants of the type I–F.
Group No. of 
strains
Predicted 
plasmids
cas 
genes
CRISPR 
arrays
Type 
I–F
Cas9- 
like
Group 
1
717 264 (25 %) 1553 
(45 %)
2628 
(95 %)
121 
(16 %)
61 (8 %)
Group 
2
1395 2091 (73 %) 110 
(2 %)
1348 
(73 %)
14 (1 %) 1 (0 %)
NT90_15810, BAV2244, ACIAD1781 and unknown126). 
Some of these genes are hypothetical proteins, but others, 
such as hdsS, are involved in a type I restriction- modification 
system, and together with the peptidase pepO, and the tran-
scriptional regulator kstR from the TetR family involved in 
antibiotic resistance, could help in blocking plasmid entrance.
One of the cas genes found in the strains of group 1 was a 
cas9- like gene that encodes the endonuclease HNH domain 
of the Cas9 protein, but not the other expected domains such 
as the RuvC domain and the PAM- interacting domain, both 
necessary for the proper functioning of this protein. This cas9- 
like gene usually appears adjacent to several other genes (tehB, 
rhpA, hsdM, vsr, hepA and uncharacterized genes named as 
unknown3592, unknown2528, unknown3372, unknown2565, 
unknown2538, p3ABAYE0073 and BUC_0564). These genes 
have functions putatively related to CRISPR systems such as 
helicase (rhpA and the protein containing a DEAD/DEAH-
 box helicase domain, hepA). For example, p3ABAYE0073 is a 
WYL domain- containing protein, and CRISPR systems have 
been predicted to be transcriptionally regulated by multiple 
ligand- binding proteins containing this kind of domain, 
which would sense modified nucleotides during foreign 
DNA entrance [45]. Strains bearing the cas9- like gene not 
only belong to the group 1 but also have a very low number 
of plasmids and a high number of CRISPR arrays, with a 
mean of 3.47±2.70 arrays per strain, which only drops to 
2.10±1.74 when considering strains with cas9- like as the only 
cas gene (Fig. 6c).
Another remarkable result was that plasmids in group 1 are 
especially enriched in toxin–antitoxin systems (Fig. S4). In 
particular, 9 genes involved in these systems and present in 
plasmids appear in 182 strains from group 1, and only 27 
from group 2: yoeB, vapC, yafQ_1, relB, dinJ, brnA, txe, yefM 
and brnT. Many of these systems have already been found 
in A. baumannii [46]. They are composed of two proteins 
coming from the same operon, where the first gene encodes 
an antitoxin that neutralizes a regulatory toxin encoded by 
the second gene. In the analysed genomes, these genes seem 
to be more frequent in strains isolated from blood cultures, 
but not in those from the perianal region. A gene coming 
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Fig. 6. Distribution of the number of plasmids between different groups together with the number of cas genes and CRISPR arrays. Each 
point represents one strain, and the number of plasmids for each strain is shown on the y- axes. The colour of the point represents the 
number of CRISPR arrays (red colour) or cas genes (blue colour). The dashed line shows the median of the plasmid number distribution, 
and the mean (dark grey dot) and sd (error bars) are also shown. Finally, the number of strains is shown for each group (n). (a) Strains 
carrying cas genes (Cas strains) versus strains without any cas gene (no- Cas strains), followed by the same two groups but now only 
showing strains with at least one plasmid carrying CRISPR arrays. (b) Strains of group 1 versus group 2, followed by the same two 
groups but now only showing strains with at least one CRISPR array in its genome. Note that the overlapping of CRISPR arrays and cas 
genes makes a purple colour. (c) Strains with cas9- like as the only cas gene versus the remaining strains.
from these systems, but in this case with a high frequency 
in both groups, is relE. This gene is a ribosome- dependent 
mRNA endoribonuclease that inhibits translation during 
amino acid starvation [47], and it is present in more than 
70 % of infective strains (isolated from blood cultures and 
respiratory airways), but in less than 50 % of the remaining 
isolation sources. Microbial toxin–antitoxin modules seem 
to have been important contributors to the evolution of 
CRISPR/Cas systems [19]. For instance, Cas2 is one of 
the key proteins in the first phase of CRISPR systems, and 
it derives from the toxins of the VapD family of mRNA 
interferases [48]. In fact, the most common unknown toxin 
mechanisms are those that indiscriminately cleave mRNAs 
inside the ribosome, resulting in microbial dormancy or 
cell death [49]. The interferases belong to several unrelated 
protein families including HEPN, RelE and VapD [50]. 
Specifically, four proteins have the HEPN domain in our 
described pangenome. All of these are uncharacterized 
proteins predicted to be in plasmids, and again appearing in 
group 1 (51 versus 3 in group 2; see Table S3). Furthermore, 
one of the analysed strains has a cluster with genes csf3, 
csf4 (also known as dinG) and cas6e, together with CRISPR 
arrays at both ends, which could constitute a CRISPR type 
IV variant.
DISCuSSIon
The current genomics era is enabling the achievement of 
large- scale genomics analysis. In this paper, we present 
what is believed to be the largest analysis of A. baumannii 
genomes conducted to date. The proposed core genome and 
pangenome agree with other smaller analyses [11, 15], and 
specially with previous forecasts expecting an exponential 
pangenome growth when a great number of genomes were 
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available [16]. Although several strains were discarded due to 
poor quality or putative misclassification, none of those came 
from non- human hosts. This fact suggests that strains from 
non- human hosts may be true A. baumannii, despite several 
authors suggesting that this species is not present in any other 
host but humans [6].
The analysis of shared genes between strains gave a bimodal 
distribution. This kind of distribution used to be related 
to a population skew or a technical mistake. For example, 
Gweon et al. in 2017 proved that bacterial genome sizes have a 
bimodal distribution due to a high sequencing effort towards 
a certain group of species [51]. However, we found two 
significant A. baumannii groups, which share specific genes 
within each group that are not present in the other group. 
In fact, one group has a high number of plasmids (and their 
genes) and the other has CRISPR/Cas genes, which could 
block plasmid entry. This is something already proposed and 
expected in CRISPR studies [19], but the presence of CRISPR/
Cas does not seem to be enough to repel the plasmids out 
of the bacterium. However, half of the strains in group 1 
specifically have genes that are involved in other bacterial 
immunity systems, such as the type I restriction- modification 
system. Type I restriction endonucleases are components of 
prokaryotic DNA restriction- modification mechanisms that 
protect the organism against invading foreign DNA [52]; 
therefore, they could complement the CRISPR/Cas systems. 
Another defence system found in several prokaryotes is the 
DND system, which labels DNA by phosphothiolation and 
destroys unmodified DNA [53]. Remarkably, only three of the 
analysed strains present two genes from this system, namely 
dndD and dndC, and they belong to group 1.
However, group 1 also has plasmids, but they seem to have 
CRISPR array sequences, which contain guide RNA, essential 
for the correct functioning of this system. Although these 
repeated sequences are usual in the bacterial chromosome, 
they can also be transported in mobile sequences. Species of 
the family Vibrionaceae are an example of this, where CRISPR 
systems identified were present predominantly within mobile 
genetic elements, including transposon- like elements and 
plasmids [54]. However, it would also suggest the presence 
of still unknown CRISPR/Cas systems, in addition to other 
complementary immunity systems. These could be related to 
toxin–antitoxin systems, which are abundant in prokaryotes 
[47]. The toxin–antitoxin systems are involved in restricting 
the growth of competing bacteria, the response to starva-
tion and other stresses and, therefore, have been linked to 
virulence [55]. In Clostridium difficile, the systems have been 
recently related to a new functional antisense RNA system, 
which is part of a type I toxin–antitoxin system adjacent 
to CRISPR arrays [56]. In fact, microbial toxin–antitoxin 
modules seem to be important contributors to the evolution 
of CRISPR/Cas systems, especially in the type IV system, 
which usually appear in plasmid sequences [19]. This obser-
vation could explain why a great number of the A. baumannii 
strains are characterized by a great number of CRISPR arrays 
in both their chromosome and plasmids, but only half of them 
have cas genes. In addition, the presence of what is believed 
to be the first described CRISPR/Cas type IV system in A. 
baumannii, and the abundance of toxin–antitoxin systems 
found in the strains of the group with a lower number of 
plasmids in this study, would support the idea that this latter 
system could contribute to the appearance of defensive 
CRISPR/Cas systems. It is important to note that we found a 
new cas9- like gene in the A. baumannii strains of the group 
that seemed to block plasmid entrance. Although it seems to 
conserve only the central endonuclease domain, the adjacent 
genes that it has, as well as the number of CRISPR arrays 
present in these strains, and the low number of plasmids 
that they possess, would suggest that it could be part of a still 
unknown functional CRISPR system.
Finally, we found genes involved in biofilm formation that 
appeared almost exclusively in the group enriched in CRISPR 
systems. The loss of function of proteins involved in CRISPR 
systems, such as the endonuclease Cas3, seems to affect to 
biofilm formation [57, 58], then CRISPR systems could help 
in the survival of the bacterium on inert surfaces, which is 
meaningful for the resistance of A. baumannii in hospitals [2].
In summary, we showed that strains of A. baumannii are 
divided into two groups that share a different number of 
genes, which could be maintained by CRISPR/Cas systems, 
some of them still not described. The group with these 
defence systems seems to have specific biofilm genes, and 
would avoid the entrance of plasmids and probably foreign 
genes, including resistance elements. These findings could 
be useful insights to help in the fight against this bacterium.
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